In vivo cardioprotection by S-nitroso-2-mercaptopropionyl glycine

Journal of Molecular and Cellular Cardiology

Volumn 46, Issue 6, 2009, Pages 960-968

  Nadtochiy, Sergiy M ^a   Burwell, Lindsay S ^a   Ingraham, Christopher A ^a   Spencer, Cody M ^a   Friedman, Alan E ^a   Pinkert, Carl A ^b   Brookes, Paul S ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b AUBURN UNIVERSITY   (United States)

Author keywords

Complex I; Ischemia; Mitochondria; Nitric oxide; Preconditioning; Reperfusion

Indexed keywords

REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); S NITROSO 2 MERCAPTOPROPIONYLGLYCINE; S NITROSOTHIOL; TIOPRONIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; ENZYME INHIBITION; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART PROTECTION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MOUSE; NITROSATION; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY;

ANIMALS; CARDIOTONIC AGENTS; ELECTRON TRANSPORT COMPLEX I; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MICE; MICE, KNOCKOUT; MITOCHONDRIA, HEART; MITOCHONDRIAL PROTEINS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; S-NITROSOTHIOLS; THIOPRONINE;

MURINAE; MUS;

EID: 67349179644     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2009.01.012     Document Type: Article

References (81)

1. Murphy E. Primary and secondary signaling pathways in early preconditioning that converge on the mitochondria to produce cardioprotection. Circ. Res. 94 (2004) 7-16
2. Murphy E., and Steenbergen C. Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol. Rev. 88 (2008) 581-609
3. Murry C.E., Jennings R.B., and Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74 (1986) 1124-1136
4. Burwell L.S., and Brookes P.S. Mitochondria as a target for the cardioprotective effects of nitric oxide in ischemia-reperfusion injury. Antioxid. Redox Signal. 10 (2008) 579-599
5. Garcia-Dorado D., Rodriguez-Sinovas A., Ruiz-Meana M., Inserte J., Agullo L., and Cabestrero A. The end-effectors of preconditioning protection against myocardial cell death secondary to ischemia-reperfusion. Cardiovasc. Res. 70 (2006) 274-285
6. Murphy E., and Steenbergen C. Preconditioning: the mitochondrial connection. Annu. Rev. Physiol. 69 (2007) 51-67
7. Hausenloy D.J., Tsang A., and Yellon D.M. The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning. Trends Cardiovasc. Med. 15 (2005) 69-75
8. Burwell L.S., Nadtochiy S.M., Tompkins A.J., Young S., and Brookes P.S. Direct evidence for S-nitrosation of mitochondrial complex I. Biochem. J. 394 (2006) 627-634
9. Nadtochiy S.M., Burwell L.S., and Brookes P.S. Cardioprotection and mitochondrial S-nitrosation: effects of S-nitroso-2-mercaptopropionyl glycine (SNO-MPG) in cardiac ischemia-reperfusion injury. J. Mol. Cell. Cardiol. 42 (2007) 812-825
10. Sun J., Morgan M., Shen R.F., Steenbergen C., and Murphy E. Preconditioning results in S-nitrosylation of proteins involved in regulation of mitochondrial energetics and calcium transport. Circ. Res. 101 (2007) 1155-1163
11. Hill B.G., and Darley-Usmar V.M. S-nitrosation and thiol switching in the mitochondrion: a new paradigm for cardioprotection in ischaemic preconditioning. Biochem. J. 412 (2008) e11-e13
12. Hess D.T., Matsumoto A., Kim S.O., Marshall H.E., and Stamler J.S. Protein S-nitrosylation: purview and parameters. Nat. Rev., Mol. Cell Biol. 6 (2005) 150-166
13. Sun J., Picht E., Ginsburg K.S., Bers D.M., Steenbergen C., and Murphy E. Hypercontractile female hearts exhibit increased S-nitrosylation of the L-type Ca2+ channel alpha1 subunit and reduced ischemia/reperfusion injury. Circ. Res. 98 (2006) 403-411
14. Xu L., Eu J.P., Meissner G., and Stamler J.S. Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation. Science 279 (1998) 234-237
15. Mannick J.B., Schonhoff C., Papeta N., Ghafourifar P., Szibor M., Fang K., et al. S-Nitrosylation of mitochondrial caspases. J. Cell Biol. 154 (2001) 1111-1116
16. Jia L., Bonaventura C., Bonaventura J., and Stamler J.S. S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature 380 (1996) 221-226
17. Clementi E., Brown G.C., Feelisch M., and Moncada S. Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 7631-7636
18. Dahm C.C., Moore K., and Murphy M.P. Persistent S-nitrosation of complex I and other mitochondrial membrane proteins by S-nitrosothiols but not nitric oxide or peroxynitrite: implications for the interaction of nitric oxide with mitochondria. J. Biol. Chem. 281 (2006) 10056-10065
19. Haendeler J., Hoffmann J., Tischler V., Berk B.C., Zeiher A.M., and Dimmeler S. Redox regulatory and anti-apoptotic functions of thioredoxin depend on S-nitrosylation at cysteine 69. Nat. Cell Biol. 4 (2002) 743-749
20. Jones S.P., and Bolli R. The ubiquitous role of nitric oxide in cardioprotection. J. Mol. Cell. Cardiol. 40 (2006) 16-23
21. Cohen M.V., Yang X.M., and Downey J.M. Nitric oxide is a preconditioning mimetic and cardioprotectant and is the basis of many available infarct-sparing strategies. Cardiovasc. Res. 70 (2006) 231-239
22. Chen Q., Moghaddas S., Hoppel C.L., and Lesnefsky E.J. Reversible blockade of electron transport during ischemia protects mitochondria and decreases myocardial injury following reperfusion. J. Pharmacol. Exp. Ther. 319 (2006) 1405-1412
23. Ockaili R.A., Bhargava P., and Kukreja R.C. Chemical preconditioning with 3-nitropropionic acid in hearts: role of mitochondrial K(ATP) channel. Am. J. Physiol, Heart Circ. Physiol. 280 (2001) H2406-H2411
24. Stowe D.F., and Kevin L.G. Cardiac preconditioning by volatile anesthetic agents: a defining role for altered mitochondrial bioenergetics. Antioxid. Redox Signal. 6 (2004) 439-448
25. Shiva S., Sack M.N., Greer J.J., Duranski M., Ringwood L.A., Burwell L., et al. Nitrite augments tolerance to ischemia/reperfusion injury via the modulation of mitochondrial electron transfer. J. Exp. Med. 204 (2007) 2089-2102
26. C.A. Ingraham, L.S. Burwell, J. Skalska, P.S. Brookes, R.L. Howell, S.-S. Sheu, et al. NDUFS4: Creation of a Mouse Model Mimicking a Complex I Disorder. Mitochondrion 2009; In revision.
27. Shishido T., Woo C.H., Ding B., McClain C., Molina C.A., Yan C., et al. Effects of MEK5/ERK5 association on small ubiquitin-related modification of ERK5: implications for diabetic ventricular dysfunction after myocardial infarction. Circ. Res. 102 (2008) 1416-1425
28. Palazzo A.J., Jones S.P., Girod W.G., Anderson D.C., Granger D.N., and Lefer D.J. Myocardial ischemia-reperfusion injury in CD18- and ICAM-1-deficient mice. Am. J. Physiol. 275 (1998) H2300-H2307
29. Dai W., and Kloner R.A. Effects of acetaminophen on myocardial infarct size in rats. J. Cardiovasc. Pharmacol. Ther. 8 (2003) 277-284
30. Mani A.R., Ebrahimkhani M.R., Ippolito S., Ollosson R., and Moore K.P. Metalloprotein-dependent decomposition of S-nitrosothiols: studies on the stabilization and measurement of S-nitrosothiols in tissues. Free Radic. Biol. Med. 40 (2006) 1654-1663
31. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
32. Tompkins A.J., Burwell L.S., Digerness S.B., Zaragoza C., Holman W.L., and Brookes P.S. Mitochondrial dysfunction in cardiac ischemia-reperfusion injury: ROS from complex I, without inhibition. Biochim. Biophys. Acta 1762 (2006) 223-231
33. Jaffrey S.R., and Snyder S.H. The biotin switch method for the detection of S-nitrosylated proteins. Sci. STKE 2001 (2001) L1
34. Wang X., Kettenhofen N.J., Shiva S., Hogg N., and Gladwin M.T. Copper dependence of the biotin switch assay: modified assay for measuring cellular and blood nitrosated proteins. Free Radic. Biol. Med. 44 (2008) 1362-1372
35. Sekili S., McCay P.B., Li X.Y., Zughaib M., Sun J.Z., Tang L., et al. Direct evidence that the hydroxyl radical plays a pathogenetic role in myocardial "stunning" in the conscious dog and demonstration that stunning can be markedly attenuated without subsequent adverse effects. Circ. Res. 73 (1993) 705-723
36. Tsutsumi Y.M., Yokoyama T., Horikawa Y., Roth D.M., and Patel H.H. Reactive oxygen species trigger ischemic and pharmacological postconditioning: in vivo and in vitro characterization. Life Sci. 81 (2007) 1223-1227
37. Wehrens X.H., Kirchhoff S., and Doevendans P.A. Mouse electrocardiography: an interval of thirty years. Cardiovasc. Res. 45 (2000) 231-237
38. Korte T., Fuchs M., Guener Z., Bonin J., de S.M., Niehaus M., et al. In-vivo electrophysiological study in mice with chronic anterior myocardial infarction. J. Interv. Card. Electrophysiol. 6 (2002) 121-132
39. Floyd J.S., Maynard C., Weston P., Johanson P., Jennings R.B., and Wagner G.S. Effects of ischemic preconditioning and arterial collateral flow on ST-segment elevation and QRS complex prolongation in a canine model of acute coronary occlusion. J. Electrocardiol. 42 (2009) 19-26
40. Kalogeropoulos A.P., Chiladakis J.A., Sihlimiris I., Koutsogiannis N., and Alexopoulos D. Predischarge QRS score and risk for heart failure after first ST-elevation myocardial infarction. J. Card. Fail. 14 (2008) 225-231
41. Weston P., Johanson P., Schwartz L.M., Maynard C., Jennings R.B., and Wagner G.S. The value of both ST-segment and QRS complex changes during acute coronary occlusion for prediction of reperfusion-induced myocardial salvage in a canine model. J. Electrocardiol. 40 (2007) 18-25
42. Pudil R., Feinberg M.S., Hod H., Boyko V., Mandelzweig L., and Behar S. The prognostic significance of intermediate QRS prolongation in acute myocardial infarction. Int. J. Cardiol. 78 (2001) 233-239
43. Zhou H.Z., Swanson R.A., Simonis U., Ma X., Cecchini G., and Gray M.O. Poly(ADP-ribose) polymerase-1 hyperactivation and impairment of mitochondrial respiratory chain complex I function in reperfused mouse hearts. Am. J. Physiol, Heart Circ. Physiol. 291 (2006) H714-H723
44. Lesnefsky E.J., Chen Q., Moghaddas S., Hassan M.O., Tandler B., and Hoppel C.L. Blockade of electron transport during ischemia protects cardiac mitochondria. J. Biol. Chem. 279 (2004) 47961-47967
45. Dabkowski E.R., Williamson C.L., and Hollander J.M. Mitochondria-specific transgenic overexpression of phospholipid hydroperoxide glutathione peroxidase (GPx4) attenuates ischemia/reperfusion-associated cardiac dysfunction. Free Radic. Biol. Med. 45 (2008) 855-865
46. Zoccarato F., Cavallini L., and Alexandre A. Respiration-dependent removal of exogenous H2O2 in brain mitochondria: inhibition by Ca2+. J. Biol. Chem. 279 (2004) 4166-4174
47. Bernardi P., Vassanelli S., Veronese P., Colonna R., Szabo I., and Zoratti M. Modulation of the mitochondrial permeability transition pore. Effect of protons and divalent cations. J. Biol. Chem. 267 (1992) 2934-2939
48. Costantini P., Chernyak B.V., Petronilli V., and Bernardi P. Modulation of the mitochondrial permeability transition pore by pyridine nucleotides and dithiol oxidation at two separate sites. J. Biol. Chem. 271 (1996) 6746-6751
49. Brookes P.S., Yoon Y., Robotham J.L., Anders M.W., and Sheu S.S. Calcium, ATP, and ROS: a mitochondrial love-hate triangle. Am. J. Physiol. Cell Physiol 287 (2004) C817-C833
50. West M.B., Hill B.G., Xuan Y.T., and Bhatnagar A. Protein glutathiolation by nitric oxide: an intracellular mechanism regulating redox protein modification. FASEB J. 20 (2006) 1715-1717
51. Hurd T.R., Requejo R., Filipovska A., Brown S., Prime T.A., Robinson A.J., et al. Complex I within oxidatively stressed bovine heart mitochondria is glutathionylated on Cys-531 and Cys-704 of the 75-kDa subunit: potential role of CYS residues in decreasing oxidative damage. J. Biol. Chem. 283 (2008) 24801-24815
52. Chandler M.P., Stanley W.C., Morita H., Suzuki G., Roth B.A., Blackburn B., et al. Short-term treatment with ranolazine improves mechanical efficiency in dogs with chronic heart failure. Circ. Res. 91 (2002) 278-280
53. Wyatt K.M., Skene C., Veitch K., Hue L., and McCormack J.G. The antianginal agent ranolazine is a weak inhibitor of the respiratory complex I, but with greater potency in broken or uncoupled than in coupled mitochondria. Biochem. Pharmacol. 50 (1995) 1599-1606
54. D'Alonzo A.J., Grover G.J., Darbenzio R.B., Hess T.A., Sleph P.G., Dzwonczyk S., et al. In vitro effects of capsaicin: antiarrhythmic and antiischemic activity. Eur. J. Pharmacol. 272 (1995) 269-278
55. Satoh T., Miyoshi H., Sakamoto K., and Iwamura H. Comparison of the inhibitory action of synthetic capsaicin analogues with various NADH-ubiquinone oxidoreductases. Biochim. Biophys. Acta 1273 (1996) 21-30
56. Anderson T.C., Li C.Q., Shao Z.H., Hoang T., Chan K.C., Hamann K.J., et al. Transient and partial mitochondrial inhibition for the treatment of postresuscitation injury: getting it just right. Crit. Care Med. 34 (2006) S474-S482
57. Anderson M.E. QT interval prolongation and arrhythmia: an unbreakable connection?. J. Intern. Med. 259 (2006) 81-90
58. Avkiran M., and Marber M.S. Na(+)/H(+) exchange inhibitors for cardioprotective therapy: progress, problems and prospects. J. Am. Coll. Cardiol. 39 (2002) 747-753
59. Cohen M.V., Yang X.M., and Downey J.M. Acidosis, oxygen, and interference with mitochondrial permeability transition pore formation in the early minutes of reperfusion are critical to postconditioning's success. Basic Res. Cardiol. 103 (2008) 464-471
60. Cohen M.V., Yang X.M., and Downey J.M. The pH hypothesis of postconditioning: staccato reperfusion reintroduces oxygen and perpetuates myocardial acidosis. Circulation 115 (2007) 1895-1903
61. Kruse S.E., Watt W.C., Marcinek D.J., Kapur R.P., Schenkman K.A., and Palmiter R.D. Mice with mitochondrial complex I deficiency develop a fatal encephalomyopathy. Cell Metab. 7 (2008) 312-320
62. Lashin O.M., Szweda P.A., Szweda L.I., and Romani A.M. Decreased complex II respiration and HNE-modified SDH subunit in diabetic heart. Free Radic. Biol. Med. 40 (2006) 886-896
63. Sugiyama S., Takasawa M., Hayakawa M., and Ozawa T. Changes in skeletal muscle, heart and liver mitochondrial electron transport activities in rats and dogs of various ages. Biochem. Mol. Biol. Int. 30 (1993) 937-944
64. Tomita M., Mukae S., Geshi E., Umetsu K., Nakatani M., and Katagiri T. Mitochondrial respiratory impairment in streptozotocin-induced diabetic rat heart. Jpn. Circ. J. 60 (1996) 673-682
65. Hassouna A., Loubani M., Matata B.M., Fowler A., Standen N.B., and Galinanes M. Mitochondrial dysfunction as the cause of the failure to precondition the diabetic human myocardium. Cardiovasc. Res. 69 (2006) 450-458
66. Ishihara M., Inoue I., Kawagoe T., Shimatani Y., Kurisu S., Nishioka K., et al. Diabetes mellitus prevents ischemic preconditioning in patients with a first acute anterior wall myocardial infarction. J. Am. Coll. Cardiol. 38 (2001) 1007-1011
67. Jahangir A., Sagar S., and Terzic A. Aging and cardioprotection. J. Appl. Physiol. 103 (2007) 2120-2128
68. Katakam P.V., Jordan J.E., Snipes J.A., Tulbert C.D., Miller A.W., and Busija D.W. Myocardial preconditioning against ischemia-reperfusion injury is abolished in Zucker obese rats with insulin resistance. Am. J. Physiol., Regul. Integr. Comp. Physiol. 292 (2007) R920-R926
69. Kersten J.R., Toller W.G., Gross E.R., Pagel P.S., and Warltier D.C. Diabetes abolishes ischemic preconditioning: role of glucose, insulin, and osmolality. Am. J. Physiol, Heart Circ. Physiol. 278 (2000) H1218-H1224
70. Riess M.L., Stowe D.F., and Warltier D.C. Cardiac pharmacological preconditioning with volatile anesthetics: from bench to bedside?. Am. J. Physiol, Heart Circ. Physiol. 286 (2004) H1603-H1607
71. Tanaka K., Kehl F., Gu W., Krolikowski J.G., Pagel P.S., Warltier D.C., et al. Isoflurane-induced preconditioning is attenuated by diabetes. Am. J. Physiol, Heart Circ. Physiol. 282 (2002) H2018-H2023
72. Davies K.J., and Doroshow J.H. Redox cycling of anthracyclines by cardiac mitochondria. I. Anthracycline radical formation by NADH dehydrogenase. J. Biol. Chem. 261 (1986) 3060-3067
73. Ohkura K., Lee J.D., Shimizu H., Nakano A., Uzui H., Horikoshi M., et al. Mitochondrials complex I activity is reduced in latent adriamycin-induced cardiomyopathy of rat. Mol. Cell. Biochem. 248 (2003) 203-208
74. Singer T.P., Ramsay R.R., and Ackrell B.A. Deficiencies of NADH and succinate dehydrogenases in degenerative diseases and myopathies. Biochim. Biophys. Acta 1271 (1995) 211-219
75. Hsu M., Srinivas B., Kumar J., Subramanian R., and Andersen J. Glutathione depletion resulting in selective mitochondrial complex I inhibition in dopaminergic cells is via an NO-mediated pathway not involving peroxynitrite: implications for Parkinson's disease. J. Neurochem. 92 (2005) 1091-1103
76. Chinta S.J., and Andersen J.K. Reversible inhibition of mitochondrial complex I activity following chronic dopaminergic glutathione depletion in vitro: implications for Parkinson's disease. Free Radic. Biol. Med. 41 (2006) 1442-1448
77. Borlongan C.V., Koutouzis T.K., and Sanberg P.R. 3-Nitropropionic acid animal model and Huntington's disease. Neurosci. Biobehav. Rev. 21 (1997) 289-293
78. Diesen D.L., Hess D.T., and Stamler J.S. Hypoxic vasodilation by red blood cells: evidence for an S-nitrosothiol-based signal. Circ. Res. 103 (2008) 545-553
79. Singel D.J., and Stamler J.S. Chemical physiology of blood flow regulation by red blood cells: the role of nitric oxide and S-nitrosohemoglobin. Annu. Rev. Physiol. 67 (2005) 99-145
80. Isbell T.S., Sun C.W., Wu L.C., Teng X., Vitturi D.A., Branch B.G., et al. SNO-hemoglobin is not essential for red blood cell-dependent hypoxic vasodilation. Nat. Med. 14 (2008) 773-777
81. Asanuma H., Nakai K., Sanada S., Minamino T., Takashima S., Ogita H., et al. S-nitrosylated and pegylated hemoglobin, a newly developed artificial oxygen carrier, exerts cardioprotection against ischemic hearts. J. Mol. Cell. Cardiol. 42 (2007) 924-930